Gaucher's disease type 3, metachromatic leukodystrophy, Niemann-Pick disease type C, pantothenate kinase- associated neurodegeneration, Tay-Sachs disease and Wilson's disease
Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies
MCT1 as a Drug Target An experimental drug from AstraZeneca, called AZD3965, blocks the activity of MCT1 and is already being clinically tested as a cancer treatment
This is why some patients feel their appetite returning even though their medication dose hasn't changed
This is the same standard applied in regulated clinical research
Why Commercial Hair Loss Products Dont Fit Every Patient The FDA-approved toolkit for androgenetic alopecia has been the same for years: oral finasteride (1 mg daily), oral dutasteride (0.5 mg, off-label in the U.S.), and topical minoxidil in 2% or 5% solutions or foam